[1] Zou Z, Sasaguri S, Rajesh KG and Suzuki R. "dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts", Am J Physiol Heart Circ Physiol, Nov; Vol. 283, No. 5. pp. H 1968–1974. (2002).
[2] Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, et al. "Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia", Jpn J Pharmacol, Vol. 89, No.1. pp.36-43. (2002).
[3] Martinez-Outschoorn UE, Pestell RG, Howell A, Tykocinski ML, Nagajyothi F, Machado FS, et al. "Energy transfer in “parasitic” cancer metabolism: mitochondria are the powerhouse and Achilles’ heel of tumor cells", Cell Cycle, Vol. 10, pp.4208–4216. (2011).
[4] Martinez-Outschoorn UE, Sotgia F and Lisanti MP. "Power surge: supporting cells “fuel” cancer cell mitochondria". Cell Metab, Vol. 15, pp.4–5. (2012).
[5] Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S and Lisanti MP. "Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms", Annu Rev Pathol, Vol. 7, pp.423–467. (2012).
[6] Warburg O., Posener K., Negelein E. "Ueber den Stoffwechsel der tumoren”, Biochem. Z. Vol. 152, pp. 319–344. (1924).
[7] Li C, Zhang G, Zhao L, Ma Z, Chen H. "Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer", World J Surg Oncol, Vol. 14, pp.15. (2016).
[8] Phan LM, Yeung SC, and Lee MH, "Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies", Cancer Biol Med, Vol.11, pp. 1-19. (2014).
[9] Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al."The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma", Cell Cycle, Vol. 8, No.23, pp.3984-4001. (2009).
[10] Martinez-Outschoorn UE, Pavldes S, Whitaker-Menezes D, Daumer KM, Millian JN, Chiaavarina B, et al. "Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors", Cell Cycle, Vol. 9, pp. 2423-2433. (2010).
[11] Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. "Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation", Cell Cycle, Vol. 9, pp. 2201-2219. (2010).
[12] Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell R, Fatatis A, et al. "The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts", Cell Cycle, Vol. 9, No.10, pp.1960-1971.( 2010).
[13] Berg JW, and Hutter RV. "Breast cancer", Cancer, Vol. 75, pp.257-269. (1995).
[14]
Fukao T,
Lopaschuk GD and
Mitchell GA. "Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry". Prostaglandins LeukotEssent Fatty Acids, Vol. 70, pp.243–251. ( 2004).
[15] Cotter DG, Schugar RC., and Crawford PA. "Ketone body metabolism and cardiovascular disease", Am J Physiol Heart Circ Physiol, Vol. 304, No. 8, pp.1060-1076. (2013).
[16] Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Lisanti MP, and Sotgia F. "Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells", Cell Cycle, Vol. 11 , pp. 3956-3963. (2012).
[17] Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, and Lisanti MP. "Ketone body utilization drives tumor growth and metastasis", Cell Cycle, Vol. 11, pp. 3964-3971. (2012).
[18] Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, and Lisanti MP. "Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment", Breast Cancer Res, Vol. 13, pp. 213. (2011).
[19] Li BL, Li XL, Duan ZJ, LeeO, Lin S and Ma ZM, et al. "Human acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that the 4.3-kilobase ACAT-1 mRNA is produced from two different chromosomes", J Biol Chem, Vol. 274. pp. 11060- 11071. (1999).
[20] Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C and Pavlides S, et al. "Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors", Cell Cycle, Vol. 10, pp. 2504-2520. (2011).
[21] Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell R and Chiavarina et al. "Ketones and lactate “fuel” tumor growth and metastasis", Cell Cycle, Vol. 9, No.17, pp. 3506-3514. (2010).